Lista de obras - Martin Eklund - Dominio Público Uruguay

A Unified Prostate Cancer Risk Prediction Model Combining the Stockholm3 Test and Magnetic Resonance Imaging

scientific article published on 09 October 2018

A genetic score can identify men at high risk for prostate cancer among men with prostate-specific antigen of 1-3 ng/ml

artículo científico publicado en 2013

A natural history model for planning prostate cancer testing: Calibration and validation using Swedish registry data

A response to "Personalised medicine and population health: breast and ovarian cancer"

artículo científico publicado en 2019

Abstract 3361: A prescription for new trial designs for drug development focused on the neoadjuvant setting: Save lives, resources, and time

scholarly article

Affinity proteomic profiling of plasma for proteins associated to area-based mammographic breast density

artículo científico publicado en 2018

Aggregate cost of mammography screening in the United States

artículo científico publicado en 2014

Aggregate cost of mammography screening in the United States: comparison of current practice and advocated guidelines

artículo científico publicado en 2014

An eScience-Bayes strategy for analyzing omics data

artículo científico publicado en 2010

Are Prostate Specific-Antigen (PSA) and age associated with the risk of ISUP Grade 1 prostate cancer? Results from 72 996 individual biopsy cores in 6 083 men from the Stockholm3 study.

artículo científico publicado en 2019

Artificial intelligence assistance significantly improves Gleason grading of prostate biopsies by pathologists

artículo científico publicado en 2020

Artificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA challenge

scientific article published on 13 January 2022

Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study

scientific article published on 08 January 2020

Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

artículo científico publicado en 2018

Association between PSA density and prostate cancer in men without significant MRI lesions

scientific article published on 28 February 2020

Associations of Breast Cancer Risk Prediction Tools With Tumor Characteristics and Metastasis

artículo científico publicado en 2015

Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

scholarly article published in Nature Genetics

Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

scholarly article published in Nature Genetics

Balancing Overdiagnosis and Early Detection of Prostate Cancer using the Stockholm-3 Model

artículo científico publicado en 2016

Benchmarking study of parameter variation when using signature fingerprints together with support vector machines

artículo científico publicado en 2014

Bioclipse 2: a scriptable integration platform for the life sciences ⬇️

artículo científico publicado en 2009

Bioclipse-R: integrating management and visualization of life science data with statistical analysis

artículo científico publicado en 2013

Bioclipse: an open source workbench for chemo- and bioinformatics ⬇️

artículo científico publicado en 2007

Biomarker discrimination and calibration with MRI-targeted biopsies: an analysis with the Stockholm3 test

scientific article published on 09 November 2020

Breast Cancer Screening in the Precision Medicine Era: Risk-Based Screening in a Population-Based Trial.

artículo científico publicado en 2017

ChemInform Abstract: Open Source Drug Discovery with Bioclipse

Chemoinformatics Taking Biology into Account: Proteochemometrics

Comparison Between the Four-kallikrein Panel and Prostate Health Index for Predicting Prostate Cancer

artículo científico publicado en 2014

Comparison of a Deep Learning Risk Score and Standard Mammographic Density Score for Breast Cancer Risk Prediction

scientific article published on 17 December 2019

Detection of Prostate Cancer Using a Multistep Approach with Prostate-specific Antigen, the Stockholm 3 Test, and Targeted Biopsies: The STHLM3 MRI Project.

artículo científico publicado en 2017

Detection of ductal carcinoma in situ and subsequent interval cancers

artículo científico publicado en 2016

Does a novel diagnostic pathway including blood-based risk prediction and MRI-targeted biopsies outperform prostate cancer screening using prostate-specific antigen and systematic prostate biopsies? - protocol of the randomised study STHLM3MRI

scientific article published on 14 June 2019

E-Science technologies in a workflow for personalized medicine using cancer screening as a case study

artículo científico publicado en 2017

Effects of increasing the PSA cutoff to perform additional biomarker tests before prostate biopsy

artículo científico publicado en 2017

Effects of pre-notification, invitation length, questionnaire length and reminder on participation rate: a quasi-randomised controlled trial

artículo científico publicado en 2018

Ethnic variation in prostate cancer detection: a feasibility study for use of the Stockholm3 test in a multiethnic U.S. cohort

scientific article published on 08 July 2020

Factors Contributing to Healthcare Professional Burnout During the COVID-19 Pandemic: A Rapid Turnaround Global Survey

scientific article published on 22 May 2020

Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants.

artículo científico publicado en 2018

Future directions in prostate cancer testing: a comment upon results from the prospective population-based diagnostic STHLM3 study-Grönberg H et al. Lancet Oncology. 2015 Nov 9; doi:10.1016/S1470-2045(15)00361-7.

artículo científico publicado en 2016

Head-to-head Comparison of Conventional, and Image- and Biomarker-based Prostate Cancer Risk Calculators

scientific article published on 22 May 2020

Identification of areas of grading difficulties in prostate cancer and comparison with artificial intelligence assisted grading

artículo científico publicado en 2020

Incorporating MRI and biomarkers in active surveillance protocols - results from the prospective Stockholm3 Active Surveillance trial (STHLM3AS)

scientific article published on 31 August 2020

Integrated decision support for assessing chemical liabilities

artículo científico publicado en 2011

Intensity of Active Surveillance and Transition to Treatment in Men with Low-risk Prostate Cancer

scientific article published on 21 June 2019

Introduction to Pharmaceutical Bioinformatics

Third edition of the book originally published in 2010

Ligand-based target prediction with signature fingerprints

artículo científico publicado en 2014

Linking the Resource Description Framework to cheminformatics and proteochemometrics ⬇️

artículo científico publicado en 2011

Lower urinary tract symptoms (LUTS) are not associated with an increased risk of prostate cancer in men 50-69 years with PSA ≥3 ng/ml

artículo científico publicado en 2019

Model building in Bioclipse Decision Support applied to open datasets

Modeling Disease Trajectories for Castration-resistant Prostate Cancer Using Nationwide Population-based Data

artículo científico publicado en 2022

Open Source Drug Discovery with Bioclipse

artículo científico publicado en 2013

Open source drug discovery with Bioclipse ⬇️

artículo científico publicado en 2012

Polygenic risk score improves prostate cancer risk prediction: results from the Stockholm-1 cohort study

artículo científico publicado en 2011

Population-based screening for cancer: hope and hype.

artículo científico publicado en 2016

Prediction of individual genetic risk to prostate cancer using a polygenic score

artículo científico publicado en 2015

Predictors of adverse pathology on radical prostatectomy specimen in men initially enrolled in active surveillance for low-risk prostate cancer

artículo científico publicado en 2020

Predictors of participation in risk-based prostate cancer screening

artículo científico publicado en 2018

Prevalence of BRCA1 and BRCA2 pathogenic variants in a large, unselected breast cancer cohort

Prognostic value of perineural invasion in prostate needle biopsies: a population-based study of patients treated by radical prostatectomy

artículo científico publicado en 2020

Prostate Cancer Diagnostics Using a Combination of the Stockholm3 Blood Test and Multiparametric Magnetic Resonance Imaging

artículo científico publicado en 2018

Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study

artículo científico publicado en 2015

Prostate-specific antigen (PSA) density in the diagnostic algorithm of prostate cancer

artículo científico publicado en 2017

Proteochemometric modeling of HIV protease susceptibility

artículo científico publicado en 2008

Proteochemometric modeling of the susceptibility of mutated variants of the HIV-1 virus to reverse transcriptase inhibitors

artículo científico publicado en 2010

Public interest in and acceptability of the prospect of risk-stratified screening for breast and prostate cancer

artículo científico publicado en 2015

Range of Radiologist Performance in a Population-based Screening Cohort of 1 Million Digital Mammography Examinations

artículo científico publicado en 2020

Re: Tobias Nordström, Andrew Vickers, Melissa Assel, Hans Lilja, Henrik Grönberg, Martin Eklund. Comparison Between the Four-kallikrein Panel and Prostate Health Index for Predicting Prostate Cancer. Eur Urol 2015;68:139-46

artículo científico publicado en 2018

Repeat Prostate-Specific Antigen Tests Before Prostate Biopsy Decisions

artículo científico publicado en 2016

Reply to Erik Rud, Peter Lauritzen, and Eduard Baco's Letter to the Editor re: Henrik Grönberg, Martin Eklund, Wolfgang Picker, et al. Prostate Cancer Diagnostics Using a Combination of the Stockholm3 Blood Test and Multiparametric Magnetic Resonanc

scientific article published on 01 December 2018

Reply to Ola Bratt and Anna Öfverholm's Letter to the Editor re: Peter Ström, Tobias Nordström, Henrik Grönberg, Martin Eklund. The Stockholm-3 Model for Prostate Cancer Detection: Algorithm Update, Biomarker Contribution, and Reflex Test Potential.

artículo científico publicado en 2018

Response to Carter et al

artículo científico publicado en 2020

Response to Walsh

scientific article published on 30 October 2018

Risk of Prostate Cancer in Men Treated With 5α-Reductase Inhibitors-A Large Population-Based Prospective Study

artículo científico publicado en 2018

Scaling predictive modeling in drug development with cloud computing

artículo científico publicado en 2015

Screening: biology dictates the fate of young women with breast cancer

artículo científico publicado en 2013

Services for prediction of drug susceptibility for HIV proteases and reverse transcriptases at the HIV drug research centre.

artículo científico publicado en 2011

Summary statement on screening for prostate cancer in Europe

artículo científico publicado en 2017

The C1C2: a framework for simultaneous model selection and assessment ⬇️

artículo científico publicado en 2008

The ProBio trial: molecular biomarkers for advancing personalized treatment decision in patients with metastatic castration-resistant prostate cancer

artículo científico publicado en 2020

The STHLM3 prostate cancer diagnostic study: calibration, clarification, and comments

artículo científico publicado en 2016

The Stockholm-3 (STHLM3) Model can Improve Prostate Cancer Diagnostics in Men Aged 50-69 yr Compared with Current Prostate Cancer Testing

artículo científico publicado en 2016

The Stockholm-3 Model for Prostate Cancer Detection: Algorithm Update, Biomarker Contribution, and Reflex Test Potential

artículo científico publicado en 2018

The Stockholm3 blood-test predicts clinically-significant cancer on biopsy: independent validation in a multi-center community cohort

artículo científico publicado en 2018

The WISDOM Personalized Breast Cancer Screening Trial: Simulation Study to Assess Potential Bias and Analytic Approaches

artículo científico publicado en 2018

The economic burden of prostate cancer - a Swedish prevalence-based register study

artículo científico publicado en 2020

The impact of different prostate-specific antigen (PSA) testing intervals on Gleason score at diagnosis and the risk of experiencing false-positive biopsy recommendations: a population-based cohort study

The importance of study design in the application of artificial intelligence methods in medicine

artículo científico publicado en 2019

The utility of artificial intelligence in the assessment of prostate pathology

artículo científico publicado en 2020

Towards Next-generation Urine-based Prostate Cancer Risk Stratification

artículo científico publicado en 2018

Towards interoperable and reproducible QSAR analyses: Exchange of datasets

artículo científico publicado en 2010

Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

artículo científico publicado en 2021

Lista de obras de Martin Eklund

A Unified Prostate Cancer Risk Prediction Model Combining the Stockholm3 Test and Magnetic Resonance Imaging

A genetic score can identify men at high risk for prostate cancer among men with prostate-specific antigen of 1-3 ng/ml

A natural history model for planning prostate cancer testing: Calibration and validation using Swedish registry data

A response to "Personalised medicine and population health: breast and ovarian cancer"

Abstract 3361: A prescription for new trial designs for drug development focused on the neoadjuvant setting: Save lives, resources, and time

Affinity proteomic profiling of plasma for proteins associated to area-based mammographic breast density

Aggregate cost of mammography screening in the United States

Aggregate cost of mammography screening in the United States: comparison of current practice and advocated guidelines

An eScience-Bayes strategy for analyzing omics data

Are Prostate Specific-Antigen (PSA) and age associated with the risk of ISUP Grade 1 prostate cancer? Results from 72 996 individual biopsy cores in 6 083 men from the Stockholm3 study.

Artificial intelligence assistance significantly improves Gleason grading of prostate biopsies by pathologists

Artificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA challenge

Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study

Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

Association between PSA density and prostate cancer in men without significant MRI lesions

Associations of Breast Cancer Risk Prediction Tools With Tumor Characteristics and Metastasis

Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

Balancing Overdiagnosis and Early Detection of Prostate Cancer using the Stockholm-3 Model

Benchmarking study of parameter variation when using signature fingerprints together with support vector machines

Bioclipse 2: a scriptable integration platform for the life sciences ⬇️

Bioclipse-R: integrating management and visualization of life science data with statistical analysis

Bioclipse: an open source workbench for chemo- and bioinformatics ⬇️

Biomarker discrimination and calibration with MRI-targeted biopsies: an analysis with the Stockholm3 test

Breast Cancer Screening in the Precision Medicine Era: Risk-Based Screening in a Population-Based Trial.

ChemInform Abstract: Open Source Drug Discovery with Bioclipse

Chemoinformatics Taking Biology into Account: Proteochemometrics

Comparison Between the Four-kallikrein Panel and Prostate Health Index for Predicting Prostate Cancer

Comparison of a Deep Learning Risk Score and Standard Mammographic Density Score for Breast Cancer Risk Prediction

Detection of Prostate Cancer Using a Multistep Approach with Prostate-specific Antigen, the Stockholm 3 Test, and Targeted Biopsies: The STHLM3 MRI Project.

Detection of ductal carcinoma in situ and subsequent interval cancers

Does a novel diagnostic pathway including blood-based risk prediction and MRI-targeted biopsies outperform prostate cancer screening using prostate-specific antigen and systematic prostate biopsies? - protocol of the randomised study STHLM3MRI

E-Science technologies in a workflow for personalized medicine using cancer screening as a case study

Effects of increasing the PSA cutoff to perform additional biomarker tests before prostate biopsy

Effects of pre-notification, invitation length, questionnaire length and reminder on participation rate: a quasi-randomised controlled trial

Ethnic variation in prostate cancer detection: a feasibility study for use of the Stockholm3 test in a multiethnic U.S. cohort

Factors Contributing to Healthcare Professional Burnout During the COVID-19 Pandemic: A Rapid Turnaround Global Survey

Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants.

Future directions in prostate cancer testing: a comment upon results from the prospective population-based diagnostic STHLM3 study-Grönberg H et al. Lancet Oncology. 2015 Nov 9; doi:10.1016/S1470-2045(15)00361-7.

Head-to-head Comparison of Conventional, and Image- and Biomarker-based Prostate Cancer Risk Calculators

Identification of areas of grading difficulties in prostate cancer and comparison with artificial intelligence assisted grading

Incorporating MRI and biomarkers in active surveillance protocols - results from the prospective Stockholm3 Active Surveillance trial (STHLM3AS)

Integrated decision support for assessing chemical liabilities

Intensity of Active Surveillance and Transition to Treatment in Men with Low-risk Prostate Cancer

Introduction to Pharmaceutical Bioinformatics

Ligand-based target prediction with signature fingerprints

Linking the Resource Description Framework to cheminformatics and proteochemometrics ⬇️

Lower urinary tract symptoms (LUTS) are not associated with an increased risk of prostate cancer in men 50-69 years with PSA ≥3 ng/ml

Model building in Bioclipse Decision Support applied to open datasets

Modeling Disease Trajectories for Castration-resistant Prostate Cancer Using Nationwide Population-based Data

Open Source Drug Discovery with Bioclipse

Open source drug discovery with Bioclipse ⬇️

Polygenic risk score improves prostate cancer risk prediction: results from the Stockholm-1 cohort study

Population-based screening for cancer: hope and hype.

Prediction of individual genetic risk to prostate cancer using a polygenic score

Predictors of adverse pathology on radical prostatectomy specimen in men initially enrolled in active surveillance for low-risk prostate cancer

Predictors of participation in risk-based prostate cancer screening

Prevalence of BRCA1 and BRCA2 pathogenic variants in a large, unselected breast cancer cohort

Prognostic value of perineural invasion in prostate needle biopsies: a population-based study of patients treated by radical prostatectomy

Prostate Cancer Diagnostics Using a Combination of the Stockholm3 Blood Test and Multiparametric Magnetic Resonance Imaging

Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study

Prostate-specific antigen (PSA) density in the diagnostic algorithm of prostate cancer

Proteochemometric modeling of HIV protease susceptibility

Proteochemometric modeling of the susceptibility of mutated variants of the HIV-1 virus to reverse transcriptase inhibitors

Public interest in and acceptability of the prospect of risk-stratified screening for breast and prostate cancer

Range of Radiologist Performance in a Population-based Screening Cohort of 1 Million Digital Mammography Examinations

Re: Tobias Nordström, Andrew Vickers, Melissa Assel, Hans Lilja, Henrik Grönberg, Martin Eklund. Comparison Between the Four-kallikrein Panel and Prostate Health Index for Predicting Prostate Cancer. Eur Urol 2015;68:139-46

Repeat Prostate-Specific Antigen Tests Before Prostate Biopsy Decisions

Reply to Erik Rud, Peter Lauritzen, and Eduard Baco's Letter to the Editor re: Henrik Grönberg, Martin Eklund, Wolfgang Picker, et al. Prostate Cancer Diagnostics Using a Combination of the Stockholm3 Blood Test and Multiparametric Magnetic Resonanc

Reply to Ola Bratt and Anna Öfverholm's Letter to the Editor re: Peter Ström, Tobias Nordström, Henrik Grönberg, Martin Eklund. The Stockholm-3 Model for Prostate Cancer Detection: Algorithm Update, Biomarker Contribution, and Reflex Test Potential.

Response to Carter et al

Response to Walsh

Risk of Prostate Cancer in Men Treated With 5α-Reductase Inhibitors-A Large Population-Based Prospective Study

Scaling predictive modeling in drug development with cloud computing

Screening: biology dictates the fate of young women with breast cancer

Services for prediction of drug susceptibility for HIV proteases and reverse transcriptases at the HIV drug research centre.

Summary statement on screening for prostate cancer in Europe

The C1C2: a framework for simultaneous model selection and assessment ⬇️

The ProBio trial: molecular biomarkers for advancing personalized treatment decision in patients with metastatic castration-resistant prostate cancer